Omnaris and Uniphyl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Omnaris (ciclesonide) and Uniphyl (theophylline). Common drug interactions include weight decreased among females and asthma among males.
The phase IV clinical study analyzes what interactions people have when they take Omnaris and Uniphyl. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Omnaris?
Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.
What is Uniphyl?
Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.
27 people who take Omnaris and Uniphyl together, and have interactions are studied.

What are the common drug interactions of Omnaris and Uniphyl, by gender? *:
female:
- Weight decreased
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Wheezing (a high-pitched whistling sound made while you breath)
- Malaise (a feeling of general discomfort or uneasiness)
- Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
- Rhinorrhoea (watery mucus discharge from the nose)
- Cough
- Hypersensitivity
- Lower respiratory tract infection
- Nasal polyps (masses that develop in the lining of the nose)
male:
- Asthma
- Chest discomfort
- Dizziness
- Dyspnoea at rest (difficult or laboured breathing during rest)
- Obstructive airways disorder (a progressive disease that makes it hard to breathe)
- Pulmonary function test decreased
- Wheezing (a high-pitched whistling sound made while you breath)
What are the common drug interactions of Omnaris and Uniphyl, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Asthma
- Hypersensitivity
- Lower respiratory tract infection
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Nasal polyps (masses that develop in the lining of the nose)
- Oropharyngeal pain
- Pneumonia
- Pulmonary congestion (congestion in the lungs)
- Respiratory disorder (respiratory disease)
- Rhinorrhoea (watery mucus discharge from the nose)
30-39:
n/a
40-49:
- Chest discomfort
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Palmar erythema (reddening of the palms at the thenar and hypothenar eminences)
- Pruritus (severe itching of the skin)
50-59:
- Asthma
- Chest discomfort
- Dizziness
- Dyspnoea at rest (difficult or laboured breathing during rest)
- Obstructive airways disorder (a progressive disease that makes it hard to breathe)
- Pulmonary function test decreased
- Wheezing (a high-pitched whistling sound made while you breath)
60+:
- Dyspnoea (difficult or laboured respiration)
- Forced expiratory volume decreased (decreased lung expired air volume)
- Increased bronchial secretion
- Increased upper airway secretion
- Intervertebral disc protrusion (spinal disc protrusion)
- Lung hyperinflation (inspiration of more than normal)
- Nerve compression
- Obstructive airways disorder (a progressive disease that makes it hard to breathe)
- Pneumonia
- Rib fracture
What are the existing conditions these people have? *
- Asthma: 23 people, 85.19%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 18.52%
- Wheezing (a high-pitched whistling sound made while you breath): 2 people, 7.41%
- Hypopnea: 2 people, 7.41%
- Dyspnea (difficult or laboured breathing): 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Omnaris and Uniphyl?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Omnaris and Uniphyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omnaris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Uniphyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omnaris and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Uniphyl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ciclesonide and theophylline (the active ingredients of Omnaris and Uniphyl, respectively), and Omnaris and Uniphyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mirtazapine cause Otitis? - 14 seconds ago
- Could Botox Cosmetic cause Hyperacusis? - 14 seconds ago
- Drug interactions of Dexilant and Melphalan - 17 seconds ago
- Could Fentanyl Transdermal System cause Road Traffic Accident? - 20 seconds ago
- Drug interactions of Enbrel and Taxol - 24 seconds ago
- Could Incruse Ellipta cause Septic Shock? - 31 seconds ago
- Could Metformin cause Pulse Pressure Decreased? - 39 seconds ago
- Drug interactions of Zomig and Wellbutrin Sr - 42 seconds ago
- Drug interactions of Vitamin D3 and Basaglar - 43 seconds ago
- Could Renvela cause Fall? - 44 seconds ago